Features of cytokine production in tumor associated with metastasis and basal cell hyperplasia of bronchial epithelium in non-small cell lung cancer
- Autores: Pismenny D.S1,2, Durova A.A2, Krahmal' N.V2, Stepanov I.V1,2, Rodionov E.O1, Eryomin V.A2, Andryuhova E.S1, Savelieva O.E1, Zavyalova M.V1,2, Pankova O.V1, Tashireva L.A1, Vtorushin S.V1,2, Miller S.V1, Tuzikov S.A1, Perelmuter V.M1
-
Afiliações:
- Cancer Research Institute, Tomsk National Research Medical Center of the RAS
- Siberian State Medical University
- Edição: Volume 16, Nº 2 (2021)
- Páginas: 54-60
- Seção: Articles
- ##submission.dateSubmitted##: 16.01.2023
- ##submission.datePublished##: 15.06.2021
- URL: https://genescells.ru/2313-1829/article/view/121911
- DOI: https://doi.org/10.23868/202107006
- ID: 121911
Citar
Texto integral
![Acesso aberto](https://genescells.ru/lib/pkp/templates/images/icons/text_open.png)
![Acesso é fechado](https://genescells.ru/lib/pkp/templates/images/icons/text_unlock.png)
![Acesso é fechado](https://genescells.ru/lib/pkp/templates/images/icons/text_lock.png)
Resumo
Palavras-chave
Texto integral
![Acesso é fechado](https://genescells.ru/lib/pkp/templates/images/icons/text_lock.png)
Sobre autores
D. Pismenny
Cancer Research Institute, Tomsk National Research Medical Center of the RAS; Siberian State Medical University
Email: pismenniy.dmitry@gmail.com
A. Durova
Siberian State Medical University
N. Krahmal'
Siberian State Medical University
I. Stepanov
Cancer Research Institute, Tomsk National Research Medical Center of the RAS; Siberian State Medical University
E. Rodionov
Cancer Research Institute, Tomsk National Research Medical Center of the RAS
V. Eryomin
Siberian State Medical University
E. Andryuhova
Cancer Research Institute, Tomsk National Research Medical Center of the RAS
O. Savelieva
Cancer Research Institute, Tomsk National Research Medical Center of the RAS
M. Zavyalova
Cancer Research Institute, Tomsk National Research Medical Center of the RAS; Siberian State Medical University
O. Pankova
Cancer Research Institute, Tomsk National Research Medical Center of the RAS
L. Tashireva
Cancer Research Institute, Tomsk National Research Medical Center of the RAS
S. Vtorushin
Cancer Research Institute, Tomsk National Research Medical Center of the RAS; Siberian State Medical University
S. Miller
Cancer Research Institute, Tomsk National Research Medical Center of the RAS
S. Tuzikov
Cancer Research Institute, Tomsk National Research Medical Center of the RAS
V. Perelmuter
Cancer Research Institute, Tomsk National Research Medical Center of the RAS
Bibliografia
- Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2018 году (заболеваемость и смертность). Москва: МНИОИ им. П.А. Герцена -Travis W.D., Brambilla E., Burke A.P. et al. World Health Organization classification of tumors of the lung, pleura, thymus, and heart. 4th Edition, Volume 7. Lyon: WHO press; 2015.
- Hicklin D.J., Ellis L.M. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J. Clin. Onc. 2005; 23(5): 1011-27.
- Eser P.O., Janne P.A. TGFp pathway inhibition in the treatment of non-small cell lung cancer. Pharmac. Ther. 2018; 184: 112-30.
- Li J., Shen C., Wang X. et al. Prognostic value of TGF-p in lung cancer: systematic review and meta-analysis. BMC Cancer 2019; 19: 691.
- Li J., Song Y., Yu B. et al. TNFAIP2 Promotes Non-Small Cell Lung Cancer Cells and Targeted by miR-145-5p. DNA and Cell Biology 2020; 39(7): 1256-63.
- Zhu J., Xin Y., Liu X. et al. Nimotuzumab enhances the sensitivity of non-small cell lung cancer cells to tumor necrosis factor-α by inhibiting the nuclear factor-α signaling pathway. Exp. Ther. Med. 2018; 15(4): 3345-51.
- Zhu T., Bao X., Chen M. et al. Mechanisms and future of non-small cell lung cancer metastasis. Front. Oncol. 2020; 10: 585284.
- Zeng Y., Wang X., Yin B. et al. Role of the stromal cell derived factor-1/CXC chemokine receptor 4 axis in the invasion and metastasis of lung cancer and mechanism. J. Thor. Dis. 2017; 9(12): 4947-59.
- Belperio J.A., Phillips R.J., Burdick M.D. et al. The SDF-1/CXCL 12/ CXCR4 biological axis in non-small cell lung cancer metastases. Chest 2004; 125(5): 156S.
- Kowanetz M., Ferrara N. Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clin. Cancer Res.2006; 12(17): 5018-22.
- Karaman S., Leppanen V.M., Alitalo K. Vascular endothelial growth factor signaling in development and disease. Development 2018; 145(14): dev151019.
- Seto T., Higashiyama M., Funai H. et al. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I. non-small-cell lung cancer. Lung Cancer 2006; 53(1): 91-6.
- Lantuejoul S., Salameire D., Salon C. et al. Pulmonary preneoplasia- sequential molecular carcinogenetic events. Histopathology 2009; 54(1): 43-54.
- Kadara H., Wistuba I.I. Molecular biology of lung preneoplasia. Lung Cancer 2014; 6: 110-28.
- Kerr K.M. Pulmonary preinvasive neoplasia. J. Clin. Path. 2001; 54(4): 257-71.
- Wang G.F., Lai M.D., Yang R.R. et al. Histological types and significance of bronchial epithelial dysplasia. Modern Path. 2006; 19(3): 429-37.
- Breuer R.H., Pasic A., Smit E.F. et al. The natural course of preneoplastic lesions in bronchial epithelium. Clin. Cancer Res. 2005; 11(2): 537-43.
- Greenberg A.K., Yee H., Rom W.N. Preneoplastic lesions of the lung. Resp. Res. 2002; 3(1): 1-10.
- Pankova O.V., Denisov E.V., Ponomaryova A.A. et al. Recurrence of squamous cell lung carcinoma is associated with the co-presence of reactive lesions in tumor-adjacent bronchial epithelium. Tumor Biology 2016; 37(3): 3599-607.
- Denisov E.V., Schegoleva A.A., Gerashchenko T.S. et al. Gene expression profiling revealed 2 types of bronchial basal cell hyperplasia and squamous metaplasia with different progression potentials. Appl. Immunohist. Mol. Morph. 2020; 28(6): 477-83.
- Petrov S.V., Raikhlin N.T. Manual on immunohistochemical diagnostics of human tumors. In: Petrov S.V., Raikhlin N.T., editors. Molecular genetic and immunohistochemical characteristics of lung cancer. 3th, completely revised edition. Kazan: Tatmedia; 2004. p. 456-61.
- Pankova O.V., Rodionov E.O., Miller S.V. et al. Neoadjuvant chemotherapy combined with intraoperative radiotherapy is effective to prevent recurrence in high-risk non-small cell lung cancer (NSCLC) patients. Transl. Lung Cancer Res. 2020; 9(4): 988.
- Tashireva L.A., Perelmuter V.M., Denisov E.V. et al. Types of immune-inflammatory responses as a reflection of cell-cell interactions under conditions of tissue regeneration and tumor growth. Biochemistry (Moscow) 2017; 82(5): 732-48.
- Kaplan R.N., Psaila B., Lyden D. Niche-to-niche migration of bone-marrow-derived cells. Trends Mol. Med. 2007; 13(2): 72-81.
- Voermans C., Anthony E.C., Mul E. et al. SDF-1-induced actin polymerization and migration in human hematopoietic progenitor cells. Exp. Hematol. 2001; 29(12): 1456-64.
- Chen H.W., Du C.W., Wei X.L. et al. Cytoplasmic CXCR4 high-expression exhibits distinct poor clinicopathological characteristics and predicts poor prognosis in triple-negative breast cancer. Curr. Mol. Med. 2013; 13(3): 410-6.
- Liu F., Lang R., Wei J. et al. Increased expression of SDF-1/ CXCR4 is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast. Histopathol. 2009; 54(6): 741-50.
- Osman N.M., Osman W.M. SDF-1 and MMP2 cross talk in cancer cells and tumor microenvironment in non-small cell lung cancer. Egypt. J. Chest Dis. and Tubercul.2016; 65(2): 517-25.
Arquivos suplementares
![](/img/style/loading.gif)